| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SH3 domain binding | 2.95e-07 | 143 | 62 | 7 | GO:0017124 | |
| GeneOntologyMolecularFunction | actin binding | WASL WIPF1 INPPL1 RUSC1 ANTXR1 COBL LMOD1 WIPF2 SHANK3 FMNL1 | 2.02e-06 | 479 | 62 | 10 | GO:0003779 |
| GeneOntologyMolecularFunction | protein domain specific binding | SCAF1 WBP11 SGIP1 WIPF1 SYNJ1 MAP4K3 ADAM15 PIK3R1 INPPL1 CASKIN1 TAMALIN SHANK3 | 1.33e-05 | 875 | 62 | 12 | GO:0019904 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CCSAP WASL SGIP1 WIPF1 INPPL1 RUSC1 ANTXR1 COBL LMOD1 WIPF2 SHANK3 FMNL1 | 1.22e-04 | 1099 | 62 | 12 | GO:0008092 |
| GeneOntologyMolecularFunction | profilin binding | 7.24e-04 | 13 | 62 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 7.24e-04 | 13 | 62 | 2 | GO:0034595 | |
| GeneOntologyMolecularFunction | inositol trisphosphate phosphatase activity | 8.43e-04 | 14 | 62 | 2 | GO:0046030 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | PTPN1 WASL MAGEL2 WIPF1 PIK3R1 INPPL1 DNAJB6 ANTXR1 COBL LMOD1 NAA80 SHANK3 FMNL1 FCHSD1 | 6.74e-08 | 803 | 61 | 14 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | PTPN1 WASL MAGEL2 WIPF1 PIK3R1 INPPL1 DNAJB6 ANTXR1 COBL LMOD1 NAA80 SHANK3 FMNL1 FCHSD1 | 3.20e-07 | 912 | 61 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin filament organization | WASL MAGEL2 WIPF1 PIK3R1 INPPL1 COBL LMOD1 NAA80 SHANK3 FCHSD1 | 2.24e-06 | 509 | 61 | 10 | GO:0007015 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | CCSAP WASL MAGEL2 WIPF1 PIK3R1 INPPL1 DNAJB6 COBL LMOD1 NAA80 SHANK3 FOXC1 FCHSD1 | 3.52e-06 | 957 | 61 | 13 | GO:0097435 |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 4.92e-05 | 222 | 61 | 6 | GO:0008154 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 1.38e-04 | 34 | 61 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | CCSAP WASL LRFN4 PIK3R1 CASKIN1 INSM1 DNAJB6 ANTXR1 COBL LMOD1 SHANK3 FCHSD1 | 1.60e-04 | 1189 | 61 | 12 | GO:0044087 |
| Domain | WH2 | 6.15e-10 | 14 | 61 | 5 | SM00246 | |
| Domain | WH2 | 1.34e-09 | 16 | 61 | 5 | PF02205 | |
| Domain | WH2_dom | 6.14e-09 | 21 | 61 | 5 | IPR003124 | |
| Domain | WH2 | 1.27e-08 | 24 | 61 | 5 | PS51082 | |
| Domain | SH3 | 7.29e-05 | 216 | 61 | 6 | SM00326 | |
| Domain | SH3 | 7.29e-05 | 216 | 61 | 6 | PS50002 | |
| Domain | SH3_domain | 8.07e-05 | 220 | 61 | 6 | IPR001452 | |
| Domain | NUT | 1.04e-04 | 5 | 61 | 2 | IPR024310 | |
| Domain | NUT_N | 1.04e-04 | 5 | 61 | 2 | IPR024309 | |
| Domain | NUT | 1.04e-04 | 5 | 61 | 2 | PF12881 | |
| Domain | SH3_2 | 1.79e-04 | 86 | 61 | 4 | IPR011511 | |
| Domain | SH3_2 | 1.79e-04 | 86 | 61 | 4 | PF07653 | |
| Domain | IPPc | 4.64e-04 | 10 | 61 | 2 | IPR000300 | |
| Domain | IPPc | 4.64e-04 | 10 | 61 | 2 | SM00128 | |
| Domain | SAM_1 | 1.43e-03 | 68 | 61 | 3 | PF00536 | |
| Domain | SH3_1 | 2.03e-03 | 164 | 61 | 4 | PF00018 | |
| Domain | SH3_9 | 2.12e-03 | 78 | 61 | 3 | PF14604 | |
| Domain | SAM | 2.99e-03 | 88 | 61 | 3 | SM00454 | |
| Domain | - | 3.24e-03 | 26 | 61 | 2 | 3.60.10.10 | |
| Domain | Exo_endo_phos | 3.24e-03 | 26 | 61 | 2 | PF03372 | |
| Domain | Endo/exonuclease/phosphatase | 3.49e-03 | 27 | 61 | 2 | IPR005135 | |
| Domain | SAM_DOMAIN | 3.71e-03 | 95 | 61 | 3 | PS50105 | |
| Domain | SAM | 3.93e-03 | 97 | 61 | 3 | IPR001660 | |
| Domain | HMGI/Y_DNA-bd_CS | 4.59e-03 | 31 | 61 | 2 | IPR000637 | |
| Domain | - | 5.04e-03 | 106 | 61 | 3 | 1.10.150.50 | |
| Domain | Ank_2 | 5.34e-03 | 215 | 61 | 4 | PF12796 | |
| Domain | SAM/pointed | 6.62e-03 | 117 | 61 | 3 | IPR013761 | |
| Domain | CYSTEINE_SWITCH | 7.93e-03 | 41 | 61 | 2 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 8.69e-03 | 43 | 61 | 2 | IPR001818 | |
| Domain | - | 8.76e-03 | 248 | 61 | 4 | 1.25.40.20 | |
| Domain | ANK | 9.13e-03 | 251 | 61 | 4 | SM00248 | |
| Domain | ANK_REPEAT | 9.38e-03 | 253 | 61 | 4 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 9.51e-03 | 254 | 61 | 4 | IPR020683 | |
| Domain | ANK_REP_REGION | 9.51e-03 | 254 | 61 | 4 | PS50297 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 1.85e-05 | 51 | 44 | 4 | M7955 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY | 1.87e-05 | 17 | 44 | 3 | M47728 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.13e-05 | 184 | 44 | 6 | M41809 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 3.63e-05 | 21 | 44 | 3 | M47722 | |
| Pathway | PID_MET_PATHWAY | 1.05e-04 | 79 | 44 | 4 | M48 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.16e-04 | 155 | 44 | 5 | M41808 | |
| Pathway | WP_INSULIN_SIGNALING | 1.34e-04 | 160 | 44 | 5 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 1.34e-04 | 160 | 44 | 5 | M39482 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 1.73e-04 | 35 | 44 | 3 | M127 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 1.73e-04 | 35 | 44 | 3 | MM15144 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.89e-04 | 36 | 44 | 3 | M27549 | |
| Pathway | BIOCARTA_CDC42RAC_PATHWAY | 1.98e-04 | 7 | 44 | 2 | MM1487 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 2.59e-04 | 40 | 44 | 3 | M62 | |
| Pathway | BIOCARTA_CDC42RAC_PATHWAY | 2.63e-04 | 8 | 44 | 2 | M5291 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 3.44e-04 | 44 | 44 | 3 | M1012 | |
| Pathway | SIG_CHEMOTAXIS | 3.67e-04 | 45 | 44 | 3 | M5193 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 5.02e-04 | 50 | 44 | 3 | MM14641 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 5.96e-04 | 53 | 44 | 3 | M662 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 6.65e-04 | 55 | 44 | 3 | M41815 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 7.46e-04 | 132 | 44 | 4 | M39338 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.01e-03 | 143 | 44 | 4 | M27107 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 1.18e-03 | 67 | 44 | 3 | M295 | |
| Pubmed | 1.33e-11 | 103 | 62 | 8 | 21706016 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 4.16e-08 | 108 | 62 | 6 | 19531213 | |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 4.90e-08 | 111 | 62 | 6 | 22558309 | |
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 22966049 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.42e-07 | 154 | 62 | 6 | 16055720 | |
| Pubmed | 2.00e-06 | 329 | 62 | 7 | 17474147 | ||
| Pubmed | CIN85 interacting proteins in B cells-specific role for SHIP-1. | 2.71e-06 | 54 | 62 | 4 | 21725061 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 27009365 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17419995 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12437929 | ||
| Pubmed | Identification of Lys-Pro-Gln as a novel cleavage site specificity of saliva-associated proteases. | 3.13e-06 | 2 | 62 | 2 | 18463091 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 26752341 | ||
| Pubmed | A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome. | 3.13e-06 | 2 | 62 | 2 | 23761422 | |
| Pubmed | WASL WBP11 PIK3R1 INPPL1 DNAJB6 COBL PPP1R13L WIPF2 PRRC2A SOS2 | 4.76e-06 | 916 | 62 | 10 | 32203420 | |
| Pubmed | The WH1 and EVH1 domains of WASP and Ena/VASP family members bind distinct sequence motifs. | 9.37e-06 | 3 | 62 | 2 | 12372256 | |
| Pubmed | Molecular genetics of human salivary proteins and their polymorphisms. | 9.37e-06 | 3 | 62 | 2 | 3055850 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 10087612 | ||
| Pubmed | WIP provides an essential link between Nck and N-WASP during Arp2/3-dependent actin polymerization. | 9.37e-06 | 3 | 62 | 2 | 23707428 | |
| Pubmed | Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. | 1.87e-05 | 4 | 62 | 2 | 26966193 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 1339347 | ||
| Pubmed | Finding new posttranslational modifications in salivary proline-rich proteins. | 1.87e-05 | 4 | 62 | 2 | 20879038 | |
| Pubmed | WIP regulates N-WASP-mediated actin polymerization and filopodium formation. | 1.87e-05 | 4 | 62 | 2 | 11331876 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 15684033 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 27588265 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 2851479 | ||
| Pubmed | 2.52e-05 | 486 | 62 | 7 | 20936779 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 11375989 | ||
| Pubmed | Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. | 3.12e-05 | 5 | 62 | 2 | 18449947 | |
| Pubmed | PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase. | 3.12e-05 | 5 | 62 | 2 | 19501627 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 24698977 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 26375204 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 23437151 | ||
| Pubmed | Wiskott-Aldrich syndrome protein is involved in alphaIIb beta3-mediated cell adhesion. | 4.67e-05 | 6 | 62 | 2 | 16582881 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 15735664 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 2993301 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 23439647 | ||
| Pubmed | All three PACSIN isoforms bind to endocytic proteins and inhibit endocytosis. | 4.67e-05 | 6 | 62 | 2 | 11082044 | |
| Pubmed | 4.67e-05 | 220 | 62 | 5 | 24550385 | ||
| Pubmed | 5.02e-05 | 963 | 62 | 9 | 28671696 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 10820259 | ||
| Pubmed | Targeting Peripheral Somatosensory Neurons to Improve Tactile-Related Phenotypes in ASD Models. | 6.53e-05 | 7 | 62 | 2 | 31398341 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 10660596 | ||
| Pubmed | A genome-wide association study of early menopause and the combined impact of identified variants. | 6.53e-05 | 7 | 62 | 2 | 23307926 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 20622009 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 18539136 | ||
| Pubmed | Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. | 1.12e-04 | 9 | 62 | 2 | 10871282 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 10744724 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.43e-04 | 1105 | 62 | 9 | 35748872 | |
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 19141316 | ||
| Pubmed | Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. | 1.89e-04 | 62 | 62 | 3 | 17975119 | |
| Pubmed | Gene variants associated with ischemic stroke: the cardiovascular health study. | 1.98e-04 | 63 | 62 | 3 | 19023099 | |
| Pubmed | Molecular markers of cardiac endocardial cushion development. | 2.41e-04 | 13 | 62 | 2 | 14648841 | |
| Pubmed | 3.19e-04 | 182 | 62 | 4 | 15102471 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 34835087 | ||
| Pubmed | Identification of Genes With Enriched Expression in Early Developing Mouse Cone Photoreceptors. | 3.23e-04 | 15 | 62 | 2 | 31260032 | |
| Pubmed | A new role for FBP21 as regulator of Brr2 helicase activity. | 3.69e-04 | 16 | 62 | 2 | 28838205 | |
| Pubmed | 3.90e-04 | 347 | 62 | 5 | 17114649 | ||
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 4.17e-04 | 81 | 62 | 3 | 20697350 | |
| Pubmed | 4.18e-04 | 17 | 62 | 2 | 14506234 | ||
| Pubmed | 4.34e-04 | 1285 | 62 | 9 | 35914814 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 4.67e-04 | 361 | 62 | 5 | 26167880 | |
| Pubmed | NANOS2 promotes male germ cell development independent of meiosis suppression. | 4.70e-04 | 18 | 62 | 2 | 24183939 | |
| Pubmed | 4.70e-04 | 18 | 62 | 2 | 19531499 | ||
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 4.73e-04 | 202 | 62 | 4 | 33601422 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 4.86e-04 | 560 | 62 | 6 | 21653829 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 5.09e-04 | 565 | 62 | 6 | 25468996 | |
| Pubmed | 5.24e-04 | 19 | 62 | 2 | 31959764 | ||
| Pubmed | 5.82e-04 | 20 | 62 | 2 | 22745308 | ||
| Pubmed | 6.44e-04 | 94 | 62 | 3 | 32062451 | ||
| Pubmed | Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. | 6.85e-04 | 96 | 62 | 3 | 34599178 | |
| Pubmed | 7.72e-04 | 23 | 62 | 2 | 19668217 | ||
| Pubmed | 7.72e-04 | 23 | 62 | 2 | 23648511 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.82e-04 | 231 | 62 | 4 | 16452087 | |
| Pubmed | 7.98e-04 | 1116 | 62 | 8 | 31753913 | ||
| Pubmed | 9.14e-04 | 25 | 62 | 2 | 12029088 | ||
| Pubmed | 9.32e-04 | 421 | 62 | 5 | 36976175 | ||
| Pubmed | WASL SGIP1 SYNJ1 MAP4K3 KIAA1217 CASKIN1 DNAJB6 PRRC2A SHANK3 | 9.37e-04 | 1431 | 62 | 9 | 37142655 | |
| Pubmed | 1.06e-03 | 251 | 62 | 4 | 27507650 | ||
| Pubmed | Identification of Arx transcriptional targets in the developing basal forebrain. | 1.15e-03 | 28 | 62 | 2 | 18799476 | |
| Pubmed | TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer. | 1.32e-03 | 30 | 62 | 2 | 34285210 | |
| Pubmed | 1.41e-03 | 31 | 62 | 2 | 19041431 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.51e-03 | 954 | 62 | 7 | 36373674 | |
| Pubmed | 1.57e-03 | 128 | 62 | 3 | 30995482 | ||
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 1.69e-03 | 34 | 62 | 2 | 30726710 | |
| Pubmed | 1.70e-03 | 285 | 62 | 4 | 34369648 | ||
| Interaction | GRB2 interactions | PTPN1 ACAP1 WASL WBP11 WIPF1 SYNJ1 MAP4K3 ADAM15 PIK3R1 INPPL1 NUTM2F WIPF2 PRRC2A SHANK3 SF3B2 SOS2 | 1.06e-09 | 806 | 60 | 16 | int:GRB2 |
| Interaction | SORBS3 interactions | 8.12e-09 | 202 | 60 | 9 | int:SORBS3 | |
| Interaction | ITSN2 interactions | 1.23e-08 | 147 | 60 | 8 | int:ITSN2 | |
| Interaction | SH3RF1 interactions | 3.19e-08 | 108 | 60 | 7 | int:SH3RF1 | |
| Interaction | NCK1 interactions | 4.17e-08 | 244 | 60 | 9 | int:NCK1 | |
| Interaction | NCK2 interactions | 7.67e-08 | 262 | 60 | 9 | int:NCK2 | |
| Interaction | PRMT2 interactions | 2.95e-07 | 91 | 60 | 6 | int:PRMT2 | |
| Interaction | SNX9 interactions | 3.05e-07 | 150 | 60 | 7 | int:SNX9 | |
| Interaction | PACSIN1 interactions | 9.51e-07 | 60 | 60 | 5 | int:PACSIN1 | |
| Interaction | PFN1 interactions | WASL SYNJ1 PIK3R1 KIAA1217 INPPL1 MLLT1 NAA80 WIPF2 FMNL1 SF3B2 | 2.35e-06 | 509 | 60 | 10 | int:PFN1 |
| Interaction | PACSIN3 interactions | 2.52e-06 | 131 | 60 | 6 | int:PACSIN3 | |
| Interaction | SH3KBP1 interactions | 4.12e-06 | 315 | 60 | 8 | int:SH3KBP1 | |
| Interaction | ABI1 interactions | 4.34e-06 | 223 | 60 | 7 | int:ABI1 | |
| Interaction | SH3GL1 interactions | 9.22e-06 | 164 | 60 | 6 | int:SH3GL1 | |
| Interaction | ITSN1 interactions | 1.15e-05 | 259 | 60 | 7 | int:ITSN1 | |
| Interaction | WIPF3 interactions | 1.37e-05 | 16 | 60 | 3 | int:WIPF3 | |
| Interaction | APBB1 interactions | 2.46e-05 | 195 | 60 | 6 | int:APBB1 | |
| Interaction | SORBS1 interactions | 3.26e-05 | 123 | 60 | 5 | int:SORBS1 | |
| Interaction | ZCCHC2 interactions | 4.26e-05 | 23 | 60 | 3 | int:ZCCHC2 | |
| Interaction | SH3D19 interactions | 5.31e-05 | 69 | 60 | 4 | int:SH3D19 | |
| Interaction | CRKL interactions | 5.76e-05 | 227 | 60 | 6 | int:CRKL | |
| Interaction | SHANK3 interactions | 1.06e-04 | 496 | 60 | 8 | int:SHANK3 | |
| Interaction | SH3GL2 interactions | 1.37e-04 | 88 | 60 | 4 | int:SH3GL2 | |
| Interaction | SRC interactions | 1.43e-04 | 664 | 60 | 9 | int:SRC | |
| Interaction | MORN4 interactions | 1.53e-04 | 35 | 60 | 3 | int:MORN4 | |
| Interaction | ACTC1 interactions | 1.99e-04 | 694 | 60 | 9 | int:ACTC1 | |
| Interaction | ABI2 interactions | 2.04e-04 | 286 | 60 | 6 | int:ABI2 | |
| Interaction | PACSIN2 interactions | 2.24e-04 | 185 | 60 | 5 | int:PACSIN2 | |
| Interaction | TRIP10 interactions | 3.13e-04 | 109 | 60 | 4 | int:TRIP10 | |
| Interaction | SORBS2 interactions | 3.35e-04 | 111 | 60 | 4 | int:SORBS2 | |
| GeneFamily | Proline rich proteins | 7.86e-05 | 6 | 42 | 2 | 972 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 6.19e-04 | 16 | 42 | 2 | 66 | |
| GeneFamily | Sterile alpha motif domain containing | 1.12e-03 | 88 | 42 | 3 | 760 | |
| GeneFamily | Ankyrin repeat domain containing | 2.35e-03 | 242 | 42 | 4 | 403 | |
| GeneFamily | Phosphoinositide phosphatases | 2.50e-03 | 32 | 42 | 2 | 1079 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 2.93e-06 | 160 | 62 | 5 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.62e-06 | 167 | 62 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.62e-06 | 167 | 62 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.69e-06 | 195 | 62 | 5 | c75d04b15d9f95fe2b5650cd4a5a376776610000 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.69e-06 | 195 | 62 | 5 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | Kidney-Mesangial|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 7.89e-06 | 196 | 62 | 5 | 2b2cbe7f96213b7ff50442593f31820d17a2ae94 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-06 | 197 | 62 | 5 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 8.08e-06 | 197 | 62 | 5 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 8.70e-06 | 200 | 62 | 5 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 8.70e-06 | 200 | 62 | 5 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-05 | 153 | 62 | 4 | 79c4f4ccdc8249c8461075c73491bc3b2d13344a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.15e-05 | 153 | 62 | 4 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 175 | 62 | 4 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 175 | 62 | 4 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 1.06e-04 | 176 | 62 | 4 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Mast_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-04 | 179 | 62 | 4 | 6153e7a0eeae83e7d88f1a20093bf2113e8d66b1 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 180 | 62 | 4 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.15e-04 | 180 | 62 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 180 | 62 | 4 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 182 | 62 | 4 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-04 | 185 | 62 | 4 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-04 | 185 | 62 | 4 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 185 | 62 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 185 | 62 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 186 | 62 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 186 | 62 | 4 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 188 | 62 | 4 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 62 | 4 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 62 | 4 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 62 | 4 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.39e-04 | 72 | 62 | 3 | 7877184d5c9dd6d96476d71e7504e58c0b4d0f26 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 189 | 62 | 4 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 189 | 62 | 4 | 4bc3826e0515b3cf2e2ef72a7b2cf9c32ade1812 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 189 | 62 | 4 | fccadf8efbef17b7f12291b069c71060a71b04e2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 189 | 62 | 4 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 190 | 62 | 4 | ce049630ed69d31f00acbc1b5b0896efc592121f | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-04 | 190 | 62 | 4 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-04 | 190 | 62 | 4 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 190 | 62 | 4 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.42e-04 | 190 | 62 | 4 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 191 | 62 | 4 | 753deb090b7b78b4ef31604dbe5dbfc4dcf5184a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 191 | 62 | 4 | 355f5bcb220d917163833dead0050fc756c7b260 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 191 | 62 | 4 | 337d7d7b89fe370e1fe005b9daad76c5dc3b8444 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 191 | 62 | 4 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 191 | 62 | 4 | 54029b68fb78163c969890886ab0f8fb0dcf3c20 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.45e-04 | 191 | 62 | 4 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.45e-04 | 191 | 62 | 4 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 1.48e-04 | 192 | 62 | 4 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.48e-04 | 192 | 62 | 4 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | T/NK_cells-CD8+_Effector_T_cell|World / Lineage and Cell class | 1.51e-04 | 193 | 62 | 4 | 79fa0f482cd98642b1d38835cda98622f21e5bd0 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-04 | 193 | 62 | 4 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.51e-04 | 193 | 62 | 4 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 194 | 62 | 4 | efd5efed060edb7f24d59600981bb60ec28ac2ef | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 194 | 62 | 4 | 906fe1689906d1498acf6fd26a215c7e5a854a38 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 194 | 62 | 4 | af7428582b96a500f255c45efc02b6c10c4740d9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 194 | 62 | 4 | 4138f3e8aa214504fca03962a43250670ae45215 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-04 | 194 | 62 | 4 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.57e-04 | 195 | 62 | 4 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-04 | 195 | 62 | 4 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-04 | 195 | 62 | 4 | 517af3e6784f02c382df6f5691945eefaa9ec4ae | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-04 | 195 | 62 | 4 | c51b1bee79e77aa2ac444a4883ef533c0095eaad | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.57e-04 | 195 | 62 | 4 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-04 | 195 | 62 | 4 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 195 | 62 | 4 | 752a100297c26732e12bbbf3ab27a2bd4f5ea06d | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 1.57e-04 | 195 | 62 | 4 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 196 | 62 | 4 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 196 | 62 | 4 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | distal-Hematologic-Natural_Killer_T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.60e-04 | 196 | 62 | 4 | 05d2a15ba702b07ef59c55891a06da02cdd15f7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 196 | 62 | 4 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 196 | 62 | 4 | 95c5b8fd4ebfae1f42de9b1475c1161d4a80e515 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-04 | 196 | 62 | 4 | 6361c37b0292ba9e5bf485a4809d2b0cd894c26e | |
| ToppCell | cellseq2|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-04 | 196 | 62 | 4 | d9e1b8386817a668eca90288b6d0e20be4138bf8 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 1.60e-04 | 196 | 62 | 4 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | distal-Hematologic-Natural_Killer_T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-04 | 197 | 62 | 4 | 5cb1b45f5dc8fbd9e54db9c943450ce2cc7000e4 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lung / Location, Cell class and cell subclass | 1.63e-04 | 197 | 62 | 4 | de26ca046038e34790cece24529a05d491e6f8ef | |
| ToppCell | mLN-(1)_T_cell-(17)_gd_T|mLN / shred on region, Cell_type, and subtype | 1.63e-04 | 197 | 62 | 4 | 5c781ded147db2f3804ee1f21ef0898c4f354890 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.63e-04 | 197 | 62 | 4 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.63e-04 | 197 | 62 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | mLN-T_cell-gd_T|mLN / Region, Cell class and subclass | 1.63e-04 | 197 | 62 | 4 | 8ef03bdbd34a874671aebfdbb7111106aa37b2a9 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | 52246d1354c4e2b13d48c878643edf843d2b50d2 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.63e-04 | 197 | 62 | 4 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | 470e23dee4ca35e1fd021b7cdd58fcbc90639837 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 198 | 62 | 4 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 198 | 62 | 4 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.66e-04 | 198 | 62 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-04 | 198 | 62 | 4 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 198 | 62 | 4 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 198 | 62 | 4 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.66e-04 | 198 | 62 | 4 | 162881a04a981741a0e26e32e0c3c694282701c6 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-04 | 198 | 62 | 4 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-04 | 198 | 62 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| Disease | serum albumin measurement | 1.57e-04 | 592 | 58 | 7 | EFO_0004535 | |
| Disease | LEOPARD Syndrome | 8.55e-04 | 22 | 58 | 2 | C0175704 | |
| Disease | suntan | 1.11e-03 | 103 | 58 | 3 | EFO_0004279 | |
| Disease | QRS-T angle | 1.20e-03 | 106 | 58 | 3 | EFO_0020097 | |
| Disease | sleep apnea measurement | 1.56e-03 | 116 | 58 | 3 | EFO_0007817 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APPPNRAPPPSRPPP | 546 | Q9H6X2 | |
| GPAKPPPPRKPLPAD | 811 | Q13444 | |
| PPRPPAAQPRPPPSP | 336 | P10323 | |
| GSPLPPASPRPPPRK | 406 | Q9C073 | |
| PRGQPPVPPKPSIRP | 536 | Q15027 | |
| GPAPRCAPPSPPPPV | 71 | Q6IQ19 | |
| PPPRRKGPLPAGPPP | 191 | Q6PCT2 | |
| FAVRPRKKGPPPPPP | 936 | Q8WXD9 | |
| PRPPPPRLPPHKPVA | 476 | Q8IVH8 | |
| PPPEHIPPPPRPPKR | 301 | P18031 | |
| PPPMRQGPPPIRPGP | 406 | Q9UJ55 | |
| AAPRGPKGPPLPPPP | 231 | Q93015 | |
| QPPPPGGKPERPPKP | 336 | P51511 | |
| PLSKVPPPPARPPPR | 266 | Q8WY41 | |
| MPPRAPPAPGPRPPP | 1 | P29122 | |
| KKGGAPAAPPPPPPP | 526 | P29536 | |
| DPPPRRPAAPPGPPG | 711 | Q8IX07 | |
| TPKPRPPRPLPVAPG | 86 | P27986 | |
| PALPPPPPPARAFGP | 296 | Q7Z6J2 | |
| PGIWPAPRGPPPPPR | 451 | Q75N03 | |
| APRGPPPPPRLQGPP | 456 | Q75N03 | |
| RPPPPPPAKAPDPGH | 671 | Q86WN1 | |
| PAQPAGLRPPKPPRP | 251 | O75190 | |
| PPNRGVPPAPPPPAA | 851 | O60741 | |
| PSPGPSPARPPAKPP | 96 | Q14184 | |
| LKEPPPPGRQPPPAP | 191 | Q12948 | |
| PAPPPGPLPPPRPMR | 31 | Q96MF6 | |
| KKRRAPAPPPPQPPP | 331 | O75128 | |
| PAGPAAPPPKQPAPP | 11 | O95466 | |
| GPPPPPPPPPRASSK | 271 | Q03111 | |
| PRPKPVDPRPPAPRP | 131 | Q9BYE0 | |
| RAGPPAPAPPAPIPP | 576 | Q8WUF5 | |
| GPPPHPGKPERPPPQ | 91 | P10163 | |
| PPPHPGKPERPPPQG | 176 | P10163 | |
| RPPPPPGKPERPPPQ | 196 | P10163 | |
| PAAALRPPGKRPPPP | 191 | Q01101 | |
| RPPGKRPPPPTAAEP | 196 | Q01101 | |
| PPPAPPRLEPRGPPA | 306 | A1L443 | |
| PPPAPPRLEPRGPPA | 306 | Q5VZR2 | |
| PPPPPVPPRRKKNRP | 401 | Q9BVN2 | |
| RPKTPPPAPAPAPGP | 791 | Q5VWG9 | |
| APLPPPPPPPARKGS | 576 | P84550 | |
| PPRQPPPPKVKPRVP | 1176 | Q07890 | |
| KRPPPPRPVAPPTRP | 1106 | O43426 | |
| VPRPPPRPPKSVPGR | 236 | H3BV60 | |
| PPGSSPPRPAAPRPP | 81 | P57071 | |
| PPRPAAPRPPPPGGV | 86 | P57071 | |
| PAPKPPLPPPHRGPA | 406 | P48634 | |
| GGKSPPPPPPPPRRS | 1041 | Q5T5P2 | |
| EKPPPTGRPPAPPRA | 936 | O15357 | |
| RGPPPPKAHPRPPLP | 1086 | O15357 | |
| PKAHPRPPLPPGPSP | 1091 | O15357 | |
| CRPPPPPPPPAGPSR | 41 | Q9C0B9 | |
| PPKPGPPRRLSAPLP | 456 | Q96EP0 | |
| KPQRPPPPGRPQGPP | 256 | Q04118 | |
| APVPRPRGPPPPPGD | 241 | Q13435 | |
| PPPPPGPRKARAPPP | 161 | M0QZC1 | |
| GPRKARAPPPPPPLR | 166 | M0QZC1 | |
| PPSPRVGKRSPPGPP | 311 | Q15772 | |
| APPAPPAPPPRGPKR | 451 | Q9BYB0 | |
| PPPRPPSRPKLPPGK | 461 | Q9BQI5 | |
| GRKPGDPPGPPRPPK | 1281 | Q9H7N4 | |
| AGPGPARPPVPPRPP | 61 | P52849 | |
| DDKPPPPPPPVGNRP | 261 | O43516 | |
| PPPARGRGAPPPPPS | 301 | O00401 | |
| APPPPPPGRRANAPP | 176 | Q8TF74 | |
| REGPPAPPPVKPPPS | 221 | Q8TF74 | |
| RDPPSRGAAPPPPPP | 316 | Q8TF74 | |
| RGKPPPPPSRTPAGP | 356 | Q8TF74 | |
| PRLPPGRKPPGPPPG | 191 | Q9Y2W2 | |
| APPAAPAPPPPKPGK | 176 | Q96N03 | |
| APPAGPPPRPRPPAP | 51 | Q6DD87 | |
| PTPKAHPPRSPPPRP | 566 | Q6PJG9 |